Evidence map›Paper›PMID 30945111›Full record

ArticleEndocrine2019

Serum IGF-binding protein 2 (IGFBP-2) concentrations change early after gastric bypass bariatric surgery revealing a possible marker of leptin sensitivity in obese subjects.

Giovanni Ceccarini, Caterina Pelosini, Federica Ferrari, Silvia Magno, Jacopo Vitti, Guido Salvetti, Carlo Moretto, Antonio Marioni, Piero Buccianti, Paolo Piaggi and 2 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06236932 (PRIN "SIDERALE"), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06236932 narecruitingnot on this mapstarted 2023, after this paper: background citation

PRIN "SIDERALE": Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation

TypeinterventionalSponsorFederico II UniversityRan2023 to 2026Enrolled100ConditionsObesity, Type2diabetes, Lipodystrophy, InfectionsArmsMediterranean diet, Melatonin supplementation
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Research Progress on Leptin in Metabolic Dysfunction-associated Fatty Liver Disease.Journal of clinical and translational hepatology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective.Advances in experimental medicine and biology · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Giovanni CeccariniObesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy. giovanni.ceccarini@unipi.it.ORCID 0000-0003-0701-642X
Caterina PelosiniObesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Federica FerrariObesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Silvia MagnoObesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Jacopo VittiObesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Guido SalvettiObesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Carlo MorettoUnit of Bariatric Surgery, University Hospital of Pisa, Pisa, Italy.
Antonio MarioniUnit of Surgery, University Hospital of Pisa, Pisa, Italy.
Piero BucciantiUnit of Surgery, University Hospital of Pisa, Pisa, Italy.
Paolo PiaggiObesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Margherita MaffeiObesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Ferruccio SantiniObesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy.
Azienda Ospedaliera Universitaria Pisana · ITIstituto di Fisiologia Clinica · ITNational Institutes of Health · USUniversity of Pisa · IT

Funding

Programma Rita Levi Montalcini (2009) na
6 · The paper itself

Abstract

purposeExpression of IGFBP-2 in mice is regulated by leptin. Over-expression of IGFBP-2 is associated with reduced caloric intake and resistance to weight gain. Hormonal variations contributing to weight loss occur very early after bariatric surgery but have not been fully elucidated. We evaluated IGFBP-2 serum changes after bariatric surgery and their relationship with leptin variations to test the hypothesis that an increase of leptin sensitivity may explain some of the effects of gastric bypass.

methodsThis is a historical prospective study. Fifty-one obese patients (41 women e 10 men), 9 non-obese surgical controls and 41 lean matched controls were studied. Serum IGFBP-2 and leptin were measured after bariatric bypass surgery at various time points up to 18 months, after non-bariatric laparoscopic surgery in a control group, and in lean matched controls.

resultsCompared to lean controls, serum IGFBP-2 levels were lower in obese patients. After gastric bypass, IGFBP-2 significantly increased at 3 days and became normal before the occurrence of relevant changes in body weight, remaining stable up to 18 months after surgery. IGFBP-2/leptin ratio increased early after surgery and became normal after one year.

conclusionsAfter gastric bypass, serum IGFBP-2 increases in a window of time when variations of hormones mediating the effects of bariatric surgery occur. Our results suggest that IGFBP-2, a leptin-regulated protein, may be an in-vivo marker of leptin action. If this is the case, an early improvement of leptin sensitivity might contribute to the anorectic effect of gastric bypass.

Indexed as

Gastric BypassAdultBiomarkersCase-Control StudiesDrug ResistanceFemaleHumansInsulin-Like Growth Factor Binding Protein 2LeptinMaleMiddle AgedObesityPostoperative PeriodPrognosisTreatment OutcomeYoung AdultBiomarkersInsulin-Like Growth Factor Binding Protein 2LeptinBariatric surgeryGastric bypassIGFBP-2Leptin sensitivityObesity

Identifiers

PMID30945111
OpenAlexW2931421335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.